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More than 100 years of research has now been conducted into the prevention,
control and elimination of rabies with safe and highly efficacious vaccines
developed for use in human and animal populations. Domestic dogs are a
major reservoir for rabies, and although considerable advances have been
made towards the elimination and control of canine rabies in many parts of
the world, the disease continues to kill tens of thousands of people every
year in Africa and Asia. Policy efforts are now being directed towards a
global target of zero human deaths from dog-mediated rabies by 2030 and
the global elimination of canine rabies. Herewe demonstrate how research pro-
vides a cause for optimism as to the feasibility of these goals through strategies
based around mass dog vaccination. We summarize some of the pragmatic
insights generated from rabies epidemiology and dog ecology research that
can improve the design of dog vaccination strategies in low- and middle-
income countries andwhich should encourage implementationwithout further
delay. We also highlight the need for realism in reaching the feasible, although
technically more difficult and longer-term goal of global elimination of canine
rabies. Finally, we discuss how research on rabies has broader relevance to the
control and elimination of a suite of diseases of current concern to human and
animal health, providing an exemplar of the value of a ‘One Health’ approach.1. Introduction
For thousands of years, people have lived in fear of rabies transmitted from dom-
estic dogs, andmore than half of theworld’s population still do so today. From the
time of the firstwritten reference to rabies in the 23rd century BC, the link between
the bite of a mad dog and the risk of human death has been well recognized [1,2].
Althoughmanymammalian hosts can be infected with the rabies virus, the dom-
estic dog remains to this day by far the most important species causing human
rabies deaths and tens of thousands of people die from canine-mediated rabies
each year [3,4], mostly in Asia and Africa where the disease is maintained in
domestic dog reservoirs.
In developing the first vaccines against rabies, Louis Pasteur recognized the
potential for eliminating human rabies deaths, and considered that ‘to solve the
problem of rabies would be a blessing for humanity’ [5]. The need for and feasi-
bility of rabies elimination through interventions in the dog population has also
been recognized for more than a century. Since the first large-scale implemen-
tation of canine vaccination in the 1920s, canine rabies has now been eliminated
in several parts of the world, for example in island and peninsula states of Asia
(e.g. Japan, Taiwan), in the USA, western Europe and across parts of Latin
America [1,6,7].
In this review, we address the reasons why, despite the long history of rabies
research and earlier successes in canine rabies elimination, new research has
been needed to tackle the problem of rabies in low- and middle-income countries
(LMICs) ofAfrica andAsia.Wedemonstrate howresearch has generated optimism
about the feasibility of achieving global targets of zero human deaths from dog-
mediated rabies, guided pragmatism in the design of dog vaccination strategies
1960 1970 1980 1990 2000 2010
pu
bl
ic
at
io
ns
 (r
ab
ies
)
0
100
200
300
400
500
0
20
40
60
80
100
o
ra
l v
ac
ci
na
tio
n 
(w
ild
lif
e)
do
g/
ca
ni
ne
 v
ac
ci
na
tio
n
1960 1970 1980 1990 2000 2010
0
100
200
300
400
500
0
10
20
30
40
50
el
im
in
at
io
n
(a) (b)
Figure 1. Number of journal articles published on rabies from 1960 to 2016 illustrating: (a) the shift in emphasis from oral vaccination of wildlife in the 1980s and
1990s to dog vaccination from 2000s; and (b) the increase in publications relating to canine rabies elimination since 2010. A search on Web of Knowledge was used
to identify journal articles: (a) articles with rabies in the title (solid black line) and of these, articles referring to oral vaccination of wildlife (solid grey line) and
canine/dog vaccination (dotted black line); and (b) articles with rabies in the title (solid black line) and, of these, articles relating to canine/dog rabies elimination
(dark grey line). Further details are provided in the electronic supplementary material. Note that dog rabies and dog rabies elimination are plotted on different axes.
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canine rabies elimination.2. Shifting priorities in rabies research
While the first decades of rabies research focused on the
problem in domestic dogs, the successful control of canine
rabies in many of the world’s richer countries shifted emphasis
towards the growing problem of wildlife rabies. During World
War II, the red fox (Vulpes vulpes) emerged as the main rabies
reservoir in Europe, and the disease spread rapidly affecting
most of western and southeastern Europe by the mid-1970s
[8]. In response, rabies research efforts focused on development
of oral rabies vaccines and vaccination strategies for wildlife
(figure 1), with large-scale distribution of oral bait vaccines
across western Europe in the 1980s and 1990s [8]. Over
25 years, oral vaccination of foxes has resulted in the elimination
of the rabies virus from western Europe, with rapid progress
being made towards elimination in eastern Europe [9].
Over this same time period, canine rabies was being
brought under control in north America, and research efforts
independently became directed to the emerging problem of
wildlife rabies focusing on control of rabies in terrestrial
carnivore reservoirs [10]. A further concern in north America
related to bat-transmitted rabies [11], coinciding with a grow-
ing interest in bats as hosts of a wider range of Lyssaviruses,
[12] and other emerging pathogens of global concern, such as
SARS coronavirus, Ebola virus and MERS coronavirus.
It is not surprising that set against this backdrop, research
into the control of canine rabies in LMICs received only lim-
ited attention during the latter part of the twentieth century
(figure 1). However, this resulted in a deficit of data and
understanding of the burden and scale of the disease in
poorer parts of the world and limited interest in potential
solutions, reinforcing a cycle of neglect [13].3. Insights from studies on the global burden
of canine rabies
It has always been known that dog bites are an important
source of human rabies exposures worldwide, but reliabledata have been lacking on the number of dog-mediated
human rabies deaths [14], with the few hundred deaths offi-
cially reported in the African region [15] widely recognized
to be a major underestimate.
An initial approach to estimating human rabies deaths in
Africa used a probability decision tree model that incorporated
data on the incidence of bite injuries from suspected rabid
dogs and availability of post-exposure prophylaxis (PEP) [16].
This was first applied in Tanzania and then used to generate
country- and regional-level estimates of human deaths across
Africa and Asia [17–21] and to assess the economic impacts of
canine rabies [22]. Further refinements resulted inmore detailed
and comprehensive estimates of global disease burden by
country [4]. These studies indicated that more than 99% of
canine-mediated rabies deaths occurred in Africa and Asia,
with a global estimate of 59 000 (95% confidence interval (CI)
25 000–159 000) deaths in 2010 [4]. Other approaches have
been adopted by the Global Burden of Disease (GBD)
collaborators, including a cause of death ensemble modell-
ing approach, which have generated estimates ranging from 54
100 deaths (95% CI 32 400–103 400) in 1990, 26 400 (95% CI 15
200–45 200) in 2010, 23 500 (95% CI 17 300–28 600) in 2013,
and 13 300 in 2016 (95% CI 7200–19 100) [3,23,24].
It is well recognized that these modelling approaches all
have limitations, particularly in the degree of extrapolation
from data that is of variable quality, from a limited geo-
graphical area or that has been generated indirectly [25].
For several neglected tropical diseases (NTDs), GBD figures
are thought likely to represent an underestimate of current
disease burden [26]. For rabies, there is no evidence that con-
trol measures have been implemented on a scale that would
explain the dramatic recent decline in deaths indicated by the
GBD estimates [23,24]. GBD estimates rely on vital regis-
tration and verbal autopsy data and these are very limited
or absent in many of the countries where rabies and other
NTDs are most prevalent [24]. Another critical issue is the
appropriate modelling of pathways from infection to disease
and death [26]. While the rabies probability tree study [4] was
also limited by data quality and availability, this analysis
incorporated detailed data from disease-specific research in
rabies-endemic countries and was based on a well-defined
series of steps from rabies exposure to death. We draw further
human cases
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Figure 2. Schematic illustrating the impacts of canine rabies and role of domestic dogs in maintaining rabies transmission (shown by solid lines). Other host species
(humans, livestock and wildlife) may be infected as a result of spillover transmission from dogs but cannot sustain cycles of infection independently (shown by
dotted lines). With the control and elimination of rabies in dogs, the virus is likely to disappear in all other species, with the potential for benefits to human,
domestic animal and wildlife health, and substantial cost savings. (Online version in colour.)
rspb.royalsocietypublishing.org
Proc.R.Soc.B
284:20171880
3
 on December 21, 2017http://rspb.royalsocietypublishing.org/Downloaded from confidence from comparison with estimates derived from
empirical studies. For example, annual human rabies deaths
in India were estimated at 20 565 through a multi-centre
community survey conducted in 2003 [27], very similar to
the figure of 20 847 deaths derived for India in 2010 through
the probability tree approach [4].
The PEP data used in the probability tree model also
provided important information for demonstrating the econ-
omic burden of canine rabies, indicating that $1.7 billion
direct costs were incurred annually in providing PEP for
29 million dog-bite victims in canine-endemic countries [4]
(figure 2). Regionally, the highest expenditure is seen in Asia
($1.4 billion annually) reflecting a continuing high demand
for PEP in areas where canine rabies has not been brought
under control, and contrasting with Latin America where,
despite much lower annual expenditure on PEP ($129 million),
the region is on the brink of eliminating canine-mediated
human rabies as a result of relatively modest investments in
mass dog vaccination ($61 million) [4]. These data contribute
to a growing body of evidence that the most cost-effective pre-
ventive strategies are those underpinned by mass dog
vaccination rather than reliance on PEP alone [28–30].
Compiling data for the global burden study also high-
lighted PEP availability as a major determinant of human
rabies deaths, with cases occurring disproportionately in impo-
verished rural communities. Detailed contact tracing studies
reveal the extent to which people have struggled to obtain
PEP and the consequences of the resulting delays [31,32],
which invariably include intense anxiety as bite victims await
an uncertain outcome and, in some cases, the development
of a horrifying and fatal disease.While human deaths and high PEP costs dominate in
burden of disease studies, several other components of dis-
ease burden are also of concern, including livestock losses,
which still remain poorly quantified but can have important
impacts [22,33] and wildlife conservation, with canine rabies
threatening several endangered wildlife populations includ-
ing the Ethiopian wolf (Canis simensis) and African wild
dog (Lycaon pictus) [34] (figure 2).4. The feasibility of canine rabies elimination:
a cause for optimism
A considerable body of research now exists to demonstrate the
feasibility of canine rabies elimination. The basic reproductive
number, R0, a key parameter used to understand the effective-
ness of control interventions, is usually measured from the
growth rates of epidemics. Applying this approach to canine
rabies demonstrates that R0 is typically between 1 and 2 in
populations that differ in density by an order of magnitude
[35–37]. Alternative approaches to estimating transmission are
all consistent with this low value of R0 [29,36,38,39] suggesting
that rabies should be easily controlled through mass dog vacci-
nation and, conversely, that approaches based on reducing dog
densityare likely to be ineffective [40]. Theoretical and empirical
research has demonstrated that rabies can be eliminated where
70% coverage is sustained [35,36]. By contrast, attempts to
reduce dog population density through indiscriminate culling
have consistently failed to control rabies outbreaks [41] and, in
some cases, have increased disease spread through human-
mediated dog movements [37]. Muzzling, restriction of dog
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dogs have historically been part of successful dog rabies control,
including in the UK and USA [1,42], but these measures are
distinguished from indiscriminate culling operations in being
specifically targeted to reduce rabies transmission risk rather
than to reduce dog population size or density.
The question of rabies reservoir dynamics has long been
debated [6,43–47], and is of major importance in sub-Saharan
Africa where the abundance of wildlife has been seen as an
obstacle for canine rabies control that would render elimination
efforts futile [15]. However, despite the fact that rabies can
infect all mammalian species, only a few hosts are capable of
maintaining infection as reservoirs, with ecological and genetic
factors both likely to be important determinants of rabies
reservoirs [46,47]. While rabies virus variants are typically
maintained by only a single mammalian host species, multiple
variants may circulate in an area [47]. However, this need not
be an insurmountable obstacle to canine rabies elimination,
as shown by countries in Latin America and in the USA,
where canine rabies has been brought under control or elimi-
nated even though rabies variants circulate in wild mammal
populations. The overlapping circulation of multiple variants
does, however, introduce different surveillance requirements
for verifying the elimination of the canine rabies variant.
Establishing the reservoir of multi host pathogens is not
easy and typically requires integration of multiple lines of evi-
dence [44,48]. In the Serengeti ecosystem, Tanzania, inference
from both epidemiological and genetic data supports the
idea of rabies being maintained in domestic dogs not wildlife,
with occasional spillover from domestic dogs into wildlife
resulting in short-lived chains of infection that are not sus-
tained [49–51]. The conclusion from these studies is that
control of canine rabies should eliminate infection in dogs,
wildlife and people. It is unclear the extent to which the Seren-
geti scenario is generalizable more globally, but currently there
is no clear evidence that, in areas with domestic dog reservoirs,
the canine rabies virus variants circulating in dogs are main-
tained independently in wildlife. In South Africa, a canine
variant circulates in jackals in the Limpopo region [52], but it
is still unknown whether this cycle will be sustained in the
absence of canine rabies, which has now been well controlled
in the area. If so, vaccination of jackals may be needed to
achieve canine rabies elimination, but this is likely to be feasible
given the demonstration of the safety, efficacy and feasibility of
oral vaccination in jackals from earlier work in Zimbabwe and
Israel [53–56].
Demonstration of the operational feasibility of mass dog
vaccination provides a further cause for optimism. Evidence
now exists to show that, contrary to widely held perceptions,
the vast majority of dogs in Africa have owners, dog accessibil-
ity is higher than often recognized, and achieving target levels
of vaccination coverage is feasible [57,58]. In south and south-
east Asia, the situationmay bemore challenging as a result of a
larger population of less accessible community or ‘street’ dogs,
but target levels of vaccination coverage have also been
achieved in these communities where campaigns are well
organized [37,59,60].
In summary, the last decade has seen a rapid expansion of
research into canine rabies vaccination and canine rabies elim-
ination (figure 1) generating optimism that canine rabies can be
effectively controlled, and ultimately eliminated, throughmass
dog vaccination and that this is the underpinning strategy
needed to reach the 2030 target for elimination of humandeaths from canine-mediated rabies [61]. The health and
economic benefits would be substantial [22] (figure 2).5. Strategies for control and elimination of
canine rabies: a case for pragmatism
While it is often recommended that a detailed understanding
of dog ecology is needed for effective canine rabies control,
the consistency of research findings generated over the past
30 years allows us to be confident in concluding that mass
dog vaccination is feasible across a wide range of settings and
campaigns can and should be initiated without delay. In
some cases, more nuanced understanding may be required to
improve coverage, but these insights can be often be gained
through implementation of control measures and used to
progressively improve the design and delivery of subsequent
interventions. Key considerations include the nature and
degree of community engagement, timing of campaigns, place-
ment of vaccination stations and whether or not to charge
owner fees [62–64]. The costs of implementing campaigns
free of charge may exceed those readily available to govern-
ment veterinary services [65], but many approaches can
still be explored to improve affordability, acceptability and
cost-effectiveness [66].
While there is widespread agreement about the central
importance of mass dog vaccination in canine rabies control
and elimination, the role of dog population management
remains the subject of debate [67]. There is a rich literature
around fertility control for management of roaming dog and
wildlife populations [68,69]. However, as rabies transmission
varies little with dog density, reproductive control measures
carried out with the aim of reducing dog density are not
likely to be effective for rabies control. In theory, reducing
population turnover (e.g. through improving life expectancy
and/or reducing fecundity) could help sustain population
immunity between campaigns and improve cost-effectiveness.
However, there is little empirical evidence that dog popu-
lation management tools have been able to achieve this [67].
Furthermore, even in populations with a high turnover,
achieving a 70% coverage during annual campaigns has
been sufficient to sustain population immunity above critical
thresholds determined by R0 [70]. The relatively high cost of
sterilization also means that strategies which combine
vaccination and sterilization are less cost-effective in terms
of achieving human health outcomes than strategies based
on dog vaccination alone, even in populations with a large
proportion of roaming dogs [39]. Improved dog population
management is undoubtedly a desirable longer-term goal
for animal health and welfare and may have important
secondary benefits for rabies control, for example by enhan-
cing community or political support [67]. However, a focus
on mass dog vaccination currently remains the most prag-
matic and cost-effective approach to canine rabies control
and elimination.
The limited availability and quality of routine animal rabies
surveillancedata inLMICs [14] hasbeen anobstacle to the appli-
cation of the analytical approaches fromwhichwe have learned
somuch aboutwildlife rabies. ‘Gold standard’ surveillancedata
based on laboratory-confirmed diagnosis is hampered not only
by limited laboratory infrastructure but also by the practical
challenges of locating, sampling and submitting specimens
[71]. However, pragmatic approaches to improving rabies
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a foundation for burden of disease estimates, data on animal-
bite injuries have been a used as a reliable indicator of canine
rabies incidence, revealing new understanding of rabies meta-
population dynamics [50], as well as improving detection of
animal rabies cases, the management of animal bites and the
cost-effectiveness of PEP [36,72].
Pragmatic solutions are also being found to improve rabies
diagnosis in settings with limited laboratory infrastructure,
including techniques to support decentralized laboratory
testing (e.g. direct rapid immunohistochemical test, dRIT)
[73–76] and field diagnosis (e.g. immunochromatographic
tests) [77–79]. These have great potential for empowering
field staff to engage in rabies surveillance and respond more
effectively to surveillance data, but standardization and quality
control of field diagnostic kits still needs improvement [80].
Given the rapid advances in metagenomic sequencing
methods [81], future approaches may include real-time geno-
mic surveillance. However, even simple technologies such as
mobile phones can serve as leapfrogging technology that can
dramatically improve the extent and resolution of rabies
surveillance data [82].6. Instilling realism on the path to elimination
While operational research on dog vaccination provides
grounds for optimism, awareness is growing about the chal-
lenges, complexities and time scales of moving from control
to elimination (figure 3).
Given the low R0 for rabies, deterministic models of trans-
mission predict that rabies should be eliminated very rapidly
[29,30,83–85]. But, these dynamic models typically assume
that dog vaccination campaigns consistently achieve high and
uniform levels of coverage. By contrast, analyses of rabies sur-
veillance and control data indicate that vaccination coverage
implemented during campaigns is often patchy and that time
to rabies elimination is prolonged [37,86,87]. Once assumptionsabout the implementation of vaccination campaigns are more
realistic, and rabies is considered on a spatial landscape,
predictions about the time scale to elimination are tempered [86].
The disparities between theory and practice demand
approaches that capture realism. It may be argued that the
feasibility and effectiveness of mass dog vaccination should
have been self-evident given the successes in Latin America
but the road to elimination has been accompanied by substan-
tial challenges [88]. Progress in Latin America has required
decades of investment in large-scale dog vaccination pro-
grammes and builds on effective regional coordination.
Sustaining such coverage, particularly across large geographi-
cal areas, is difficult and requires an investment in rabies
control that focuses on the dog population and is over and
above levels seen to date in Africa and Asia [65]. Local leader-
ship is also an important factor. For example, canine rabies in
north America was primarily controlled at the municipal
level through dog licensure. Legislation and by-laws relating
to rabies control and dog vaccination exist in many canine
rabies-endemic countries, but there is still a need for greater
engagement of local authorities to ensure appropriate and
sensitive enforcement of relevant legislation.
Empirical evidence from wildlife rabies elimination
programmes show that once controlled to less than 10% of
endemic incidence, the time required to eliminate rabies is as
long again [9], a lesson that should be heeded for canine
rabies. Once rabies has been reduced to low levels, the remain-
ing foci by their nature are persistent and in ‘hard-to-reach’
communities, socially, economically and geographically, and
new challenges come to the fore [89].
Increasingly the importance of metapopulations has been
recognized for the persistence of rabies [38,50] and genomic
signatures in rabies-endemic countries highlight the frequent
human-mediatedmovement of dogs [90–92]. The implications
of this movement are evident when rabies invades previously
uninfected areas [37], andwithoutmaintained vigilance, rabies
can re-emerge rapidly if control measures are no longer
implemented effectively [93]. The long-term implications of
rspb.royalso
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understood but will, undoubtedly prolong elimination efforts,
and highlight the need for coordinated control at scale and
across international boundaries as well as realistic projections
of the investment required to eliminate rabies [94].cietypublishing.org
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284:201718807. Rabies research as a driver of policy change
Recent research has contributed pivotal evidence in making the
case for rabies to be considered a priority NTD and, in 2012,
rabies was included within the World Health Organization
(WHO)AcceleratedRoadmap forNTDs [95]. In 2016, the tripar-
tite partnership (WHO, the World Organization for Animal
Health (OIE), and the Food and Agriculture Organization of
the United Nations (FAO), together with the Global Alliance
for Rabies Control, declared a goal of zero human deaths
from dog-mediated rabies by 2030 [61], underpinned by an
investment case incorporating data on the human health and
economic burden of canine rabies [4,22]. This purposely sets
dog-mediated human rabies deaths as the first target, both
because of its public health importance, but also its shorter-
term feasibility (figure 3) through a combination of mass dog
vaccination and improved PEP provision to under-served com-
munities. The longer-term goal of disrupting transmission and
eliminating canine rabies will require more time. Nonetheless,
the example of Latin America demonstrates that it is within
reach [88].
The control and elimination of canine rabies provides an
exemplar of ‘One Health’ interventions, that is, interventions
in animal populations that generate human health benefits.
Although challenges remain in the operationalization of
One Health [96], these approaches not only provide the
most cost-effective strategy for preventing human rabies
deaths but also offer a more equitable approach than relying
only on interventions directed at humans only (i.e. PEP) [97].
Interventions that effectively reduce the force of infection
from the animal reservoir convey benefits to all without
regard to socioeconomic status. By contrast, under a strategy
of reliance on PEP, the social, political and economic factors
constraining access to healthcare are likely to prevail, with
rabies deaths continuing to affect the most disadvantaged
communities well beyond 2030.
It is perhaps understandable that the medical sector
emphasizes prevention of human rabies through PEP. But
this approach can lead to neglect of the problem at source—
in the dogs—and impede progress towards large-scale mass
dog vaccination programmes. This is true even in upper
middle-income countries which have clear capability to
implement mass dog vaccination but, without effectiveprogrammes, still suffer a high burden of human deaths and
an escalation in PEP demand, with costs amounting to tens
of millions of dollars every year [4].8. Conclusion
Recent research on rabies has generated a strong body of
evidence for the feasibility of elimination of canine rabies
through mass vaccination of domestic dogs. Global momen-
tum is now building towards implementation of large-scale
programmes to achieve first, the elimination of human deaths
mediated by canine rabies, and second, disruption of trans-
mission within the dog population and the elimination of
canine rabies entirely. However, time is short to reach these
global targets [61] and there is no cause for further delay.
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